Is there a recognised cardio-oncology group or society in your country?

Sweden has an active cardio-oncology community, with growing multidisciplinary collaboration aimed at improving the care of patients experiencing cardiovascular complications of cancer and cancer therapies. While dedicated cardio-oncology services remain limited, increasing awareness of the field has led to the establishment of collaborative clinical structures and educational activities across the country.

Clinical Practice

Dedicated clinics specifically focused on cardio-oncology are currently limited in Sweden. Long-term follow-up clinics for childhood cancer survivors represent the most established specialised services addressing the late effects of cancer treatment, including cardiovascular complications. Similar initiatives are currently being explored to support the long-term care of young adult cancer survivors.

In addition to these dedicated survivorship programmes, almost all university hospitals, as well as several regional hospitals, have established multidisciplinary teams or case conferences involving cardiologists, oncologists, and other healthcare professionals. These multidisciplinary collaborations facilitate the management of patients with both short- and long-term cardiovascular complications related to cancer treatment and support coordinated decision-making in complex cases.

Education

Cardio-oncology education in Sweden is largely delivered through regional educational initiatives and continuing professional development programmes. These activities provide opportunities for healthcare professionals to increase their knowledge of cardiovascular complications associated with cancer therapies and to remain updated on emerging evidence in the field.

At the national level, cardio-oncology is regularly represented during the annual Cardiovascular Spring Meeting, the official scientific congress of the Swedish Association of Cardiology. The meeting typically includes one or two dedicated cardio-oncology sessions, providing an important forum for education, scientific exchange, and discussion of contemporary clinical challenges.

Research

Sweden has a strong tradition of research in cardio-oncology, with substantial scientific activity across a broad range of topics related to cancer therapy–associated cardiovascular disease. Research efforts have contributed to improving the understanding of cardiotoxicity mechanisms, risk assessment, long-term cardiovascular outcomes among cancer survivors, and strategies for prevention and management.

The continued growth of research activity, combined with increasing multidisciplinary collaboration, is expected to further strengthen the development of cardio-oncology services and evidence-based care throughout Sweden.